To study the effect of Shamanaushadhi (Nirgundi Guggulu with Rasnaerandadi Kashaya) along with various combinations of Valuka Sweda in Tennis Elbow for adults with age group of 20-60 years for a period of 45 days

A four arm exploratory clinical study to evaluate the efficacy of Shamanaushadhi along with various combinations of Valuka Sweda in the management of Tennis Elbow - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071560

Enrollment

200

Registered

2024-07-30

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M771- Lateral epicondylitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects diagnosed with Tennis elbow based on any signs and symptoms such as Pain in elbow joint, swelling in elbow joint, difficulty in gripping objects and lifting them. 2.Subjects diagnosed with any of the three stages of Tennis Elbow. 3.Subjects of age group of 20 to 60 years of either sex. Sub categorization of age group from 20-60 years as follows: 20-30 years, 30-40 years, 40-50 years, 50-60 years. 4.Subjects fit for scheduled treatment protocol.

Exclusion criteria

Exclusion criteria: 1.Subjects with other degenerative and inflammatory arthritic conditions and Auto immune joint disorders such as Rheumatoid arthritis, Osteo Arthritis, Gout, Osteoporosis, Osteo Myelitis, SLE and Polymyalgia Rheumatis. 2.Subjects with history of fractures, avascular necrosis and Carcinoma of bones. 3.Subjects suffering with Neurological pain and other neurological defects such as neuropathy. 4.Subjects suffering with muscular pain due to Myopathies, Muscular Dystrophy, Fibromyalgia. 5.Subjects with underlying Systemic diseases like Uncontrolled Diabetes Mellitus, Hypertension, Thyroid disorders. 6.Pregnant and Lactating women. 7.Subjects with Malignant tumors, HIV, HBSAg and Tuberculosis.

Design outcomes

Primary

Measure	Time frame
Improvements noticed in Reduction in Pain and Swelling.Timepoint: Baseline, 7th day, 14th day, 21st day,28th day,35th day,42nd day	—

Secondary

Measure	Time frame
Improvements noticed based on COZEN’s Test and MAUDSLEY’S TESTTimepoint: Baseline, 7th day, 14th day, 21st day,28th day,35th day,42nd day	—

Countries

India

Contacts

Public ContactDr Sowjanya J

Ayurveda Mahavidyalaya, Hubbali

drprashanthas@gmail.com9448135575

Outcome results